NL7201180A - - Google Patents

Info

Publication number: NL7201180A
Authority: NL; Netherlands

Application number

NL7201180A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-02-12

Filing date

1972-01-28

Publication date

1972-08-15

1972-01-28 Application filed filed Critical

1972-08-15 Publication of NL7201180A publication Critical patent/NL7201180A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NL7201180A 1971-02-12 1972-01-28 NL7201180A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11504271A	1971-02-12	1971-02-12

Publications (1)

Publication Number	Publication Date
NL7201180A true NL7201180A (da)	1972-08-15

Family

ID=22358980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL7201180A NL7201180A (da)	1971-02-12	1972-01-28

Country Status (10)

Country	Link
US (1)	US3700673A (da)
AU (1)	AU454474B2 (da)
BE (1)	BE779153A (da)
DE (1)	DE2206674A1 (da)
FR (1)	FR2125403B1 (da)
GB (1)	GB1328322A (da)
IL (1)	IL38564A (da)
NL (1)	NL7201180A (da)
SE (1)	SE368706B (da)
ZA (1)	ZA72389B (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3984551A (en) *	1970-10-05	1976-10-05	Imperial Chemical Industries Limited	Pharmaceutical compositions comprising pyridoquinoline derivatives and the use thereof
IL87861A0 (en) *	1987-10-05	1989-03-31	Pfizer	4-aminopyridine derivatives
US6635642B1 (en)	1997-09-03	2003-10-21	Guilford Pharmaceuticals Inc.	PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6426415B1 (en)	1997-09-03	2002-07-30	Guilford Pharmaceuticals Inc.	Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6197785B1 (en)	1997-09-03	2001-03-06	Guilford Pharmaceuticals Inc.	Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6346536B1 (en)	1997-09-03	2002-02-12	Guilford Pharmaceuticals Inc.	Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6514983B1 (en)	1997-09-03	2003-02-04	Guilford Pharmaceuticals Inc.	Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6291425B1 (en)	1999-09-01	2001-09-18	Guilford Pharmaceuticals Inc.	Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6121278A (en) *	1997-09-03	2000-09-19	Guilford Pharmaceuticals, Inc.	Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
US6391005B1 (en)	1998-03-30	2002-05-21	Agilent Technologies, Inc.	Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
CA2332279A1 (en) *	1998-05-15	1999-11-25	Jia-He Li	Carboxamide compounds, compositions, and methods for inhibiting parp activity
US6395749B1 (en)	1998-05-15	2002-05-28	Guilford Pharmaceuticals Inc.	Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6380193B1 (en)	1998-05-15	2002-04-30	Guilford Pharmaceuticals Inc.	Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
US6387902B1 (en)	1998-12-31	2002-05-14	Guilford Pharmaceuticals, Inc.	Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
WO2001090077A1 (en)	2000-05-19	2001-11-29	Guilford Pharmaceuticals, Inc.	Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
WO2001091796A2 (en)	2000-06-01	2001-12-06	Guilford Pharmaceuticals Inc.	Methods, compounds and compositions for treating gout
US6545011B2 (en)	2000-07-13	2003-04-08	Guilford Pharmaceuticals Inc.	Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses
ZA200300255B (en) *	2000-07-20	2004-09-28	Bristol Myers Squibb Pharma Co	Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors.
US6596729B2 (en) *	2000-07-20	2003-07-22	Bristol-Myers Squibb Company	Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
US8641644B2 (en)	2000-11-21	2014-02-04	Sanofi-Aventis Deutschland Gmbh	Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
JP4323802B2 (ja) *	2000-12-01	2009-09-02	エムジーアイ・ジーピー・インコーポレーテッド	化合物およびその使用
US7981056B2 (en)	2002-04-19	2011-07-19	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US9795747B2 (en)	2010-06-02	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Methods and apparatus for lancet actuation
AU2002348683A1 (en)	2001-06-12	2002-12-23	Pelikan Technologies, Inc.	Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US9427532B2 (en)	2001-06-12	2016-08-30	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
ES2336081T3 (es)	2001-06-12	2010-04-08	Pelikan Technologies Inc.	Dispositivo de puncion de auto-optimizacion con medios de adaptacion a variaciones temporales en las propiedades cutaneas.
ATE485766T1 (de)	2001-06-12	2010-11-15	Pelikan Technologies Inc	Elektrisches betätigungselement für eine lanzette
US9226699B2 (en)	2002-04-19	2016-01-05	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling module with a continuous compression tissue interface surface
US7041068B2 (en)	2001-06-12	2006-05-09	Pelikan Technologies, Inc.	Sampling module device and method
US8337419B2 (en)	2002-04-19	2012-12-25	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US9248267B2 (en)	2002-04-19	2016-02-02	Sanofi-Aventis Deustchland Gmbh	Tissue penetration device
US8267870B2 (en)	2002-04-19	2012-09-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for body fluid sampling with hybrid actuation
US8221334B2 (en)	2002-04-19	2012-07-17	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US9795334B2 (en)	2002-04-19	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7547287B2 (en)	2002-04-19	2009-06-16	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7674232B2 (en)	2002-04-19	2010-03-09	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7901362B2 (en)	2002-04-19	2011-03-08	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7226461B2 (en)	2002-04-19	2007-06-05	Pelikan Technologies, Inc.	Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7491178B2 (en)	2002-04-19	2009-02-17	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8702624B2 (en)	2006-09-29	2014-04-22	Sanofi-Aventis Deutschland Gmbh	Analyte measurement device with a single shot actuator
US7909778B2 (en)	2002-04-19	2011-03-22	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US9314194B2 (en)	2002-04-19	2016-04-19	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US7232451B2 (en)	2002-04-19	2007-06-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7229458B2 (en)	2002-04-19	2007-06-12	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8579831B2 (en)	2002-04-19	2013-11-12	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7331931B2 (en)	2002-04-19	2008-02-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8784335B2 (en)	2002-04-19	2014-07-22	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling device with a capacitive sensor
US8360992B2 (en)	2002-04-19	2013-01-29	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7297122B2 (en)	2002-04-19	2007-11-20	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7976476B2 (en)	2002-04-19	2011-07-12	Pelikan Technologies, Inc.	Device and method for variable speed lancet
US7175642B2 (en)	2002-04-19	2007-02-13	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US8574895B2 (en)	2002-12-30	2013-11-05	Sanofi-Aventis Deutschland Gmbh	Method and apparatus using optical techniques to measure analyte levels
EP1628567B1 (en)	2003-05-30	2010-08-04	Pelikan Technologies Inc.	Method and apparatus for fluid injection
EP1633235B1 (en)	2003-06-06	2014-05-21	Sanofi-Aventis Deutschland GmbH	Apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en)	2004-06-14	2006-01-05	Pelikan Technologies, Inc.	Low pain penetrating
EP1671096A4 (en)	2003-09-29	2009-09-16	Pelikan Technologies Inc	METHOD AND APPARATUS FOR PROVIDING IMPROVED SAMPLE CAPTURING DEVICE
US9351680B2 (en)	2003-10-14	2016-05-31	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a variable user interface
EP1706026B1 (en)	2003-12-31	2017-03-01	Sanofi-Aventis Deutschland GmbH	Method and apparatus for improving fluidic flow and sample capture
WO2006011062A2 (en)	2004-05-20	2006-02-02	Albatros Technologies Gmbh & Co. Kg	Printable hydrogel for biosensors
US9775553B2 (en)	2004-06-03	2017-10-03	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a fluid sampling device
WO2005120365A1 (en)	2004-06-03	2005-12-22	Pelikan Technologies, Inc.	Method and apparatus for a fluid sampling device
WO2009126900A1 (en)	2008-04-11	2009-10-15	Pelikan Technologies, Inc.	Method and apparatus for analyte detecting device
US9375169B2 (en)	2009-01-30	2016-06-28	Sanofi-Aventis Deutschland Gmbh	Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en)	2010-04-16	2015-02-24	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1058338A (fr) *	1952-06-13	1954-03-16	Ward	Aza acridines comportant un substituant en méso et leur préparation
DE1022593B (de) *	1952-06-21	1958-01-16	Ward Blenkinsop & Co Ltd	Verfahren zur Herstellung von 1-Aza-acridinen
US3232945A (en) *	1962-08-13	1966-02-01	S E Massengill Company	7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US3580915A (en) *	1968-09-16	1971-05-25	American Home Prod	1,2,3,4-tetrahydrobenzol(b)(1,6)naphthyridine derivatives

1971
- 1971-02-12 US US115042A patent/US3700673A/en not_active Expired - Lifetime
1972
- 1972-01-14 IL IL38564A patent/IL38564A/en unknown
- 1972-01-20 ZA ZA720389A patent/ZA72389B/xx unknown
- 1972-01-21 AU AU38174/72A patent/AU454474B2/en not_active Expired
- 1972-01-28 NL NL7201180A patent/NL7201180A/xx unknown
- 1972-02-02 GB GB493772A patent/GB1328322A/en not_active Expired
- 1972-02-08 SE SE01451/72A patent/SE368706B/xx unknown
- 1972-02-09 BE BE779153A patent/BE779153A/xx unknown
- 1972-02-11 DE DE19722206674 patent/DE2206674A1/de active Pending
- 1972-02-11 FR FR7204700A patent/FR2125403B1/fr not_active Expired

Also Published As

Publication number	Publication date
FR2125403A1 (da)	1972-09-29
US3700673A (en)	1972-10-24
IL38564A0 (en)	1972-03-28
GB1328322A (en)	1973-08-30
ZA72389B (en)	1973-09-26
AU454474B2 (en)	1974-10-31
BE779153A (fr)	1972-08-09
IL38564A (en)	1974-11-29
FR2125403B1 (da)	1975-04-25
AU3817472A (en)	1973-07-26
DE2206674A1 (de)	1972-08-31
SE368706B (da)	1974-07-15

Publication	Publication Date	Title
FR2125403B1 (da)	1975-04-25
AU2691671A (da)	1972-09-28
AU2564071A (da)	1972-08-24
AU2684071A (da)	1972-09-28
AU2726271A (da)	1972-10-05
AU2742671A (da)	1972-10-12
AU2894671A (da)	1972-11-23
AU2941471A (da)	1972-11-30
AU2952271A (da)	1972-12-07
AU3005371A (da)	1972-12-21
AU2875571A (da)	1972-11-16
AU2836771A (da)	1972-11-09
AU2880771A (da)	1972-11-16
AU2684171A (da)	1971-07-15
AU2706571A (da)	1971-07-15
AU2724971A (da)	1972-10-05
AU2456871A (da)	1972-08-17
AU2740271A (da)	1972-10-12
AU2755871A (da)	1972-10-19
AU2837671A (da)	1972-11-09
AU2854371A (da)	1972-11-09
AU2588771A (da)	1972-08-31
AU3038671A (da)	1973-01-04
AU3025871A (da)	1973-01-04
AU2885171A (da)	1972-11-16